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Summary 
Postoperative complications such as surgical site infections, dehiscence, seromas, and hematomas prolong 
wound care and impose significant cost increases to patients and healthcare providers. Clinicians aiming to 
reduce the incidence of these complications should be aware of risk factors associated with surgical type, 
procedures used, patient characteristics, and postoperative care. Today, improved guidelines and general 
practices for managing surgical incisions have reduced the incidence of complications to historic lows. In 
addition to these standard care options, advanced wound care approaches have been extensively studied and exist 
as options for clinicians to provide adjunctive postoperative support and facilitate wound healing. These systems 
include advanced wound dressings and closed-incision negative-pressure therapy. Advanced wound care is not 
appropriate in all settings, and healthcare providers must assess each case for specific needs to be addressed by 
the available incision management plans. Emerging therapies that are intended to improve the continuum of 
postoperative care should continue to be evaluated in controlled clinical trials to determine their effectiveness 
under different circumstances and to support the creation of more robust guidelines for their use. 
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Introduction 
Postoperative complications following the 45 million operations performed each year in the United States result 
in substantial morbidity and costs.1 Common complications include surgical site infections (SSIs), dehiscences, 
and development of seromas or hematomas. These complications delay hospital discharge, prolong wound care, 
and lead to the need for additional invasive procedures. The increased morbidity and costs associated with 
complications motivate healthcare providers to be vigilant in recognizing risk factors arising from patient 
comorbidities or circumstances of surgery. Current clinical research continues to provide evidence for new 
techniques that aim at reducing the incidence of these complications.  
 
COMMON SURGICAL SITE OCCURRENCES. 
Among postoperative complications, SSIs are one of the most prevalent, accounting for 21.8% of the ≈721,800 
healthcare-associated infections reported annually.2 Each incident increases the average hospital stay by 9.6 days 
at an additional cost of $38,656, which results in over $10 billion in direct and indirect costs annually.3 In 
addition to a monetary cost, the presence of an SSI is associated with the occurrence of other complications and 
a higher 30-day mortality rate.4 Common risk factors associated with SSI are listed in Table 1. Dehiscence of a 
closed surgical wound is often preceded by the presence of an SSI,6,7 with some medical researchers reporting 
dehiscence and SSI as interchangeable. However, the exact relationship between SSI and dehiscence is difficult 
to determine due to the lack of reliable standardized data and discrepant recording methodologies.8 Another 
common surgical site complication is the formation of seromas or hematomas at the incision site, typically when 
an anatomical space has been created. In either case, both can increase tension at the incision, making these sites 
more prone to infection.9 
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Table NO 1. 
 
 
SURGERY-SPECIFIC RISK FACTORS. 
 Risks of surgery have been related to various factors including the location, type, and surgical duration. Patients 
receiving emergency surgery or complex operations have a higher than average risk of experiencing SSIs.4 
Increased duration of operations is also associated with elevated number of surgical site occurrences. Among 
surgery types, specific procedures can also hold higher risk of SSI than others (Table 2). The rate of SSI within 
30 days of surgery ranges 3%–4% for integumentary, musculoskeletal, respiratory, and oral surgeries, while the 
rate is slightly higher (4%–5%) for surgical resolution of vascular abnormalities.4 Abdominal surgeries have the 
highest 30-day rate of SSIs, at over 6%. Hernia repair overall maintains a low 30-day SSI rate of 55 years of age, 
wound infection, emergency surgery, and steroid use.6,13  
 
MANAGEMENT OF SURGICAL SITE OCCURRENCES. 
Common practices for managing postoperative incisions typically include placement of a nonadherent or silver-
impregnated material on the incision, followed by sterile gauze or abdominal pads.14 Incidence of surgical 
complications has been reduced by improvement in operating room ventilation, instrument sterilization 
procedures, maximum barrier protection requirements, and the use of prophylactic antibiotics. Preoperative 
cleaning of the surgical site with antiseptic solutions is another common practice with the intention of reducing 
SSIs; however, multiple meta-analyses have found sparse evidence demonstrating any benefit against SSI 
incidence.15,16  
 
ADVANCED WOUND CARE.  
In addition to the first-line treatment practices, there have been attempts by medical researchers to identify other 
advanced wound care strategies that might reduce the risk of postoperative complications. One approach 
includes the application of antimicrobial advanced wound dressings (AWDs) over the closed incision. In a 
single-center retrospective review of 903 patients with total joint arthroplasty, a silver-releasing, cellulose-based 
antimicrobial AWD was more effective than conventional dressings in reducing the incidence of periprosthetic 
joint infections.17 In a prospective, randomized controlled trial (RCT) of a different silver-eluting antimicrobial 
AWD used postoperatively in patients after lower extremity arterial reconstruction, intervention with AWD 
failed to show a significant benefit reducing wound complications.18 Another technology that has been used to 
enhance postsurgery wound healing is closed-incision negative-pressure therapy (ciNPT), which creates a closed 
wound environment and applies negative pressure using a foam dressing. Highquality studies have also reported 
benefits of ciNPT in postoperative complications. An RCT involving 102 patients with groin incisions found that 
those treated with ciNPT had a significantly shorter mean duration of hospital stay compared (6 days) with a 
control group (9 days).19 A second RCT of 100 patients with 129 groin incisions reported that patients treated 
with ciNPT exhibited a significant reduction in 30-day wound infections (2.3% versus 17.5%, respectively) and 
revision surgeries (1.7% versus 14.1%, respectively) compared to patients who received standard care.20 
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Table No 2. 
 
In an RCT investigating postcesarean wound morbidity in 82 patients, patients treated with ciNPT had 
fewer surgical site occurrences (5.1%) than a control group receiving standard care (16.3%). Patients with ciNPT 
also experienced reduced incisional pressure (54.3% versus 91.3%, respectively).21 A 2015 meta-analysis of 8 
controlled studies involving a total of 1,277 patients found that ciNPT provided a significant reduction in SSI 
risk. However, there was no significant impact of ciNPT on risk of dehiscence and hematoma.22 In a 
retrospective analysis of 138 revision hip and knee operations comparing a silver-releasing, cellulose-based 
AWD to ciNPT, the ciNPT group exhibited a significantly reduced number of complications in general, and SSIs 
specifically.23 It is important to note that not all surgical incisions may benefit from ciNPT. In an RCT 
following 81 patients at high risk of surgical site complications with multiple comorbidities after lower extremity 
and abdominal surgery, there was no significant difference in SSI or dehiscence between patient groups treated 
with dry dressings compared to those receiving ciNPT.24 Therefore, attention should be paid to specific 
characteristics of the patient and surgery procedure to determine whether the patient would benefit from ciNPT. 
ciNPT has been rapidly introduced into clinical medicine, and we are still learning which patients will best 
benefit from this, and trying to better understand the mechanisms of action. Surgeons have proposed a number of 
mechanisms of action such as relieving tension along the incision, altering the blood flow to the wound, 
changing the kinetics of lymphangiogenesis, and reducing fluid and infectious materials. The molecular basis for 
each of these mechanisms continues to be developed. 
 
CONCLUSIONS. 
Surgical site occurrences pose a substantial threat to patient health and can result in costly or invasive 
interventions, making use of adequate prevention practices a necessity. Healthcare practitioners should assess the 
patient’s risk of postoperative complications by taking into account patient comorbidities, the quality of the 
surgical site, and the characteristics of the operation itself. Although standard protocols have improved to reduce 
incidence of surgical site complications, emerging advanced wound care technologies may provide additional 
benefit in select circumstances. These new therapies must continue to be evaluated to better define their 
appropriate use and determine improved protocols for decreasing complication risk. 
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